Department of Medicine, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Indian J Med Res. 2021 Aug;154(2):199-209. doi: 10.4103/ijmr.IJMR_879_20.
Cardiovascular disease (CVD) and breast cancer cause substantial morbidity and mortality in women and are major public health concerns. Breast cancer survivors are at a greater risk for CVD-related mortality compared to women without breast cancer. Breast cancer and cardiovascular diseases share a number of common risk factors. Breast cancer treatments like anthracycline based chemotherapy, novel targeted therapy and radiation therapy can cause cardiotoxicity. With improvements in breast cancer prevention and treatment, there is a significant improvement in survival and this shifts focus from disease control to long term effects of treatment and quality of life. Assessing CVD and minimizing complications from cancer therapy are important treatment goals.
心血管疾病（CVD）和乳腺癌在女性中导致大量发病率和死亡率，是主要的公共卫生关注点。与没有乳腺癌的女性相比，乳腺癌幸存者患与 CVD 相关的死亡率的风险更高。乳腺癌和心血管疾病有许多共同的危险因素。乳腺癌治疗，如基于蒽环类药物的化疗、新型靶向治疗和放射治疗，可导致心脏毒性。随着乳腺癌预防和治疗的改善，生存率显著提高，这将重点从疾病控制转移到治疗的长期影响和生活质量上。评估 CVD 并最大限度地减少癌症治疗的并发症是重要的治疗目标。
